BROADCASTS.com

Every week, The American Journal of Managed Care\xae\xa0(AJMC\xae) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\n\nThis week, the top managed care news included\xa0a new investigation into drug prices; FDA Commissioner Scott Gottlieb, MD, provided updates on how the government shutdown is impacting FDA work; research found comorbidities impede clinical trial participation for patients with cancer.\n\nRead more about the stories in this podcast:\nBiologics, Diabetes, Cancer Drugs on House Oversight Probe List: https://www.ajmc.com/newsroom/biologics-diabetes-cancer-drugs-on-house-oversight-probe-list\nHHS Medicare Drug Shift Plan Could Reduce Costs Overall but Raise Them for Some, Researchers Say: https://www.ajmc.com/newsroom/hhs-medicare-drug-shift-plan-could-reduce-costs-overall-but-raise-them-for-some-researchers-say\nWhat We're Reading: FDA Resumes Some Inspections; Walmart Leaves CVS' PBM Networks; Flu Season: https://www.ajmc.com/newsroom/what-were-reading-fda-resumes-some-inspections-walmart-leaves-cvss-pbm-networks-flu-season\nComorbidities Impede Clinical Trial Participation Among Patients With Cancer: https://www.ajmc.com/focus-of-the-week/comorbidities-impede-clinical-trial-participation-among-patients-with-cancer\nUnderstanding What Drives Health Information Exchange Use During Postacute Care Transitions: https://www.ajmc.com/managed-care-cast/understanding-what-drives-health-information-exchange-use-during-postacute-care-transitions\nThe American Journal of Managed Care\u2014January 2019, Health IT Issue: https://www.ajmc.com/journals/issue/2019/2019-vol25-n1